Cargando…
Author Correction: Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma
Autores principales: | Younis, Nancy S., Ghanim, Amal M. H., Saber, Sameh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365839/ https://www.ncbi.nlm.nih.gov/pubmed/35948610 http://dx.doi.org/10.1038/s41598-022-17580-7 |
Ejemplares similares
-
Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma
por: Younis, Nancy S., et al.
Publicado: (2019) -
Author Correction: Viral Bcl2s’ transmembrane domain interact with host Bcl2 proteins to control cellular apoptosis
por: García-Murria, Maria Jesús, et al.
Publicado: (2021) -
Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma
por: Swetha, Mundanattu, et al.
Publicado: (2022) -
Author Correction: Melting enhancement of PCM in a finned tube latent heat thermal energy storage
por: Ahmed, Sameh, et al.
Publicado: (2022) -
Author Correction: Bcl11b controls odorant receptor class choice in mice
por: Enomoto, Takayuki, et al.
Publicado: (2019)